Abstracts - faqs.org

Abstracts

Zoology and wildlife conservation

Search abstracts:
Abstracts » Zoology and wildlife conservation

Placebo or no placebo?

Article Abstract:

A novel approach to evaluating a drug to treat patients with AIDS (acquired immunodeficiency syndrome) is being taken by British and French researchers. AIDS patients will have the option of participating in a standard randomized trial (Option A), in which they will be randomly assigned to a high-dose or a low-dose dideoxyinosine (ddI) group, or to a placebo (inactive drug) control group. If patients choose Option B they will participate in a randomized trial in which they will only be assigned to either of the two ddI groups. Such 'compassionate release' of the drug is in response to pressure from AIDS activists against the drug's producer, Bristol-Meyers Squibb, and the Food and Drug Administration (FDA). Suprisingly, some patients have already registered for Option A. Tony Pinching, who will be in charge of the British studies, estimated that because of 'compassionate release' about ten times as many people have received ddI than in the more controlled studies demanded by protocols in the United States. Zidovudine (AZT) is presently the only drug licensed in Britain for treating AIDS patients, but 30 to 40 percent of the patients receiving AZT must stop treatment because of side effects, such as nausea and anorexia (loss of appetite). ddI works in a manner similar to that of AZT and it is known to decrease the amount of HIV (Human immunodeficiency) virus, the virus that causes AIDS) in the blood of AIDS patients, but it has not yet shown the clinical benefits produced by AZT. (Consumer Summary produced by Reliance Medical Information, Inc.)

Author: Aldhous, Peter
Publisher: Macmillan Publishing Ltd.
Publication Name: Nature
Subject: Zoology and wildlife conservation
ISSN: 0028-0836
Year: 1990
Usage, Testing, Drug therapy, Antiviral agents, AIDS (Disease), Placebos

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


The toads are coming!

Article Abstract:

Buffo marinus known as cane toad in Australian landscape are forwarding to the city in Darwin. The scientists are present with their best opportunity to investigate the ecological impact of the amphibians in Darwin.

Author: Aldhous, Peter
Publisher: Macmillan Publishing Ltd.
Publication Name: Nature
Subject: Zoology and wildlife conservation
ISSN: 0028-0836
Year: 2004
Australia, Behavior, Environmental aspects, Amphibians, Toads, Darwin, Australia

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Similar abstracts:
  • Abstracts: Pictures, words and the brain. The brain's dictionary. Separable processing of consonants and vowels
  • Abstracts: I love you to death. The roar from Ano Nuevo. Zoo-to-you: the Albuquerque Biological Park reaches out
  • Abstracts: Back from the dead. When the going gets tough. Tissue donations slump after revelations about misuse
  • Abstracts: ICI transfers most of its research to new Zeneca biosciences company
  • Abstracts: Harvest of hope. Sleepless in Seattle. Back in business
This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.
Some parts © 2026 Advameg, Inc.